Literature DB >> 7588402

Cloning of cDNA encoding an NAD(+)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase in sheep kidney.

A K Agarwal1, T Mune, C Monder, P C White.   

Abstract

11 beta-Hydroxysteroid dehydrogenase (11-HSD) catalyzes the conversion of cortisol to cortisone and corticosterone to 11-dehydrocorticosterone. This activity may be required to confer normal ligand specificity upon the mineralocorticoid receptor. Although an isozyme of 11-HSD was previously isolated from rat liver, a different isozyme is apparently expressed in mineralocorticoid target tissues. We isolated a sheep kidney cDNA clone encoding this isozyme by expression screening using Xenopus oocytes. The cDNA is 1.8 kb in length and encodes a protein of 427 amino acid residues with a predicted M(r) of 46,700. When expressed in oocytes, this enzyme functions as an NAD(+)-dependent 11 beta-hydrogenase with very high affinity for steroids, but it has no detectable reductase activity. It is 37% identical in amino acid sequence to an NAD(+)-dependent isozyme of 17 beta-hydroxysteroid dehydrogenase, but only 20% identical to the NADP(+)-dependent liver isozyme of 11-HSD. It is expressed at high levels in the kidney and adrenal and at lower levels in the colon. The corresponding gene is present in a single copy in the sheep genome. In humans, this gene is a candidate locus for the syndrome of apparent mineralocorticoid excess, a form of hypertension postulated to result from 11-HSD deficiency in mineralocorticoid target tissues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7588402     DOI: 10.3109/07435809509030455

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  4 in total

1.  Ligand-receptor interaction between triterpenoids and the 11beta-hydroxysteroid dehydrogenase type 2 (11betaHSD2) enzyme predicts their toxic effects against tumorigenic r/m HM-SFME-1 cells.

Authors:  Hideaki Yamaguchi; Tao Yu; Toshiro Noshita; Yumi Kidachi; Katsuyoshi Kamiie; Kenji Yoshida; Tatsuo Akitaya; Hironori Umetsu; Kazuo Ryoyama
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

2.  Molecular docking and structural analysis of cofactor-protein interaction between NAD⁺ and 11β-hydroxysteroid dehydrogenase type 2.

Authors:  Hideaki Yamaguchi; Tatsuo Akitaya; Tao Yu; Yumi Kidachi; Katsuyoshi Kamiie; Toshiro Noshita; Hironori Umetsu; Kazuo Ryoyama
Journal:  J Mol Model       Date:  2011-06-11       Impact factor: 1.810

3.  Diethylstilbestrol inhibits human and rat 11β-hydroxysteroid dehydrogenase 2.

Authors:  Yiyan Wang; Yaoyao Dong; Yinghui Fang; Yao Lv; Qiqi Zhu; Xiaoheng Li; Qingquan Lian; Ren-Shan Ge
Journal:  Endocr Connect       Date:  2019-07       Impact factor: 3.335

4.  Zearalenone Inhibits Rat and Human 11β-Hydroxysteroid Dehydrogenase Type 2.

Authors:  Linxi Li; Xiaolong Wu; Hongguo Guan; Baiping Mao; Huang Wang; Xiaohuan Yuan; Yanhui Chu; Jianliang Sun; Ren-Shan Ge
Journal:  Biomed Res Int       Date:  2015-12-20       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.